Aberrant anabolism hinders constructive metabolism of chondrocytes by pharmacotherapy in osteoarthritis
Open Access
- 5 March 2025
- journal article
- Published by British Editorial Society of Bone & Joint Surgery in Bone & Joint Research
- Vol. 14 (3) , 199-207
Abstract
Osteoarthritis (OA) is a highly prevalent and disabling disease with an unmet therapeutic need. The characteristic cartilage loss and alteration of other joint structures result from a complex interaction of multiple risk factors, with mechanical overload consistently playing a central role. This overload generates an inflammatory response in the cartilage due to the activation of the innate immune response in chondrocytes, which occurs through various cellular mechanisms. Moreover, risk factors associated with obesity, being overweight, and metabolic syndrome enhance the inflammatory response both locally and systemically. OA chondrocytes, the only cells present in articular cartilage, are therefore inflamed and initiate an anabolic process in an attempt to repair the damaged tissue, which ultimately results in an aberrant and dysfunctional process. Under these circumstances, where the cartilage continues to be subjected to chronic mechanical stress, proposing a treatment that stimulates the chondrocytes’ anabolic response to restore tissue structure does not appear to be a therapeutic target with a high likelihood of success. In fact, anabolic drugs proposed for the treatment of OA have yet to demonstrate efficacy. By contrast, multiple therapeutic strategies focused on pharmacologically managing the inflammatory component, both at the joint and systemic levels, have shown promise. Therefore, prioritizing the control of chronic innate pro-inflammatory pathways presents the most viable and promising therapeutic strategy for the effective management of OA. As research continues, this approach may offer the best opportunity to alleviate the burden of this incapacitating disease.Cite this article: Bone Joint Res 2025;14(3):199–207.Keywords
This publication has 96 references indexed in Scilit:
- The role of synovitis in osteoarthritis pathogenesisBone, 2012
- Nonsteroidal antiinflammatory drugs and prostaglandin E2 modulate the synthesis of osteoprotegerin and RANKL in the cartilage of patients with severe knee osteoarthritisArthritis & Rheumatism, 2010
- Long-term NSAID treatment directly decreases COX-2 and mPGES-1 production in the articular cartilage of patients with osteoarthritisOsteoarthritis and Cartilage, 2008
- Regulation of chondrogenesis and chondrocyte differentiation by stressJournal of Clinical Investigation, 2008
- Crystal Structure of the TLR4-MD-2 Complex with Bound Endotoxin Antagonist EritoranCell, 2007
- TGF-β and osteoarthritisOsteoarthritis and Cartilage, 2007
- FGF18 is required for early chondrocyte proliferation, hypertrophy and vascular invasion of the growth plateDevelopmental Biology, 2007
- Long term NSAID treatment inhibits COX-2 synthesis in the knee synovial membrane of patients with osteoarthritis: differential proinflammatory cytokine profile between celecoxib and aceclofenacAnnals of the Rheumatic Diseases, 2006
- Non-steroidal anti-inflammatory drugs, including cyclo-oxygenase-2 inhibitors, in osteoarthritic knee pain: meta-analysis of randomised placebo controlled trialsBMJ, 2004
- Glucosamine inhibits IL-1β-induced NFκB activation in human osteoarthritic chondrocytesOsteoarthritis and Cartilage, 2003